Healthcare -
Biotechnology - NASDAQ - US
$ 1.81
2.84 %
$ 1.15 B
Market Cap
-6.7
P/E
GERN - REVENUE
Revenue GERN - Geron Corporation
237 K
LAST VALUE
-58.75%
2 YEAR CAGR
-25.97%
5 YEAR CAGR
-15.54%
10 YEAR CAGR